Edition:
United States

Tandem Diabetes Care Inc (TNDM.OQ)

TNDM.OQ on NASDAQ Stock Exchange Global Market

26.89USD
20 Jul 2018
Change (% chg)

$0.28 (+1.05%)
Prev Close
$26.61
Open
$26.63
Day's High
$27.24
Day's Low
$26.12
Volume
329,565
Avg. Vol
529,022
52-wk High
$27.86
52-wk Low
$2.14

Latest Key Developments (Source: Significant Developments)

Tandem Diabetes Care Announces FDA Approval Of TSlim X2 Insulin Pump
Thursday, 21 Jun 2018 04:05pm EDT 

June 21 (Reuters) - Tandem Diabetes Care Inc ::TANDEM DIABETES CARE ANNOUNCES FDA APPROVAL OF T:SLIM X2 INSULIN PUMP WITH BASAL-IQ TECHNOLOGY.TANDEM DIABETES CARE INC - NEW PREDICTIVE LOW GLUCOSE SUSPEND FEATURE TO LAUNCH WITH DEXCOM G6 CGM SYSTEM INTEGRATION.TANDEM DIABETES CARE INC - TANDEM EXPECTS T:SLIM X2 PUMP WITH BASAL-IQ TECHNOLOGY TO BE AVAILABLE IN AUGUST 2018.  Full Article

Tandem Diabetes Care Files For Mixed Shelf Of Up To $100 Mln
Thursday, 26 Apr 2018 04:05pm EDT 

April 26 (Reuters) - Tandem Diabetes Care Inc ::TANDEM DIABETES CARE INC FILES FOR MIXED SHELF OF UP TO $100 MILLION - SEC FILING.  Full Article

Tandem Diabetes Care Q1 Sales $27 Mln Vs I/B/E/S View $25 Mln
Tuesday, 10 Apr 2018 08:30am EDT 

April 10 (Reuters) - Tandem Diabetes Care Inc ::TANDEM DIABETES CARE ANNOUNCES PRELIMINARY FIRST QUARTER 2018 RESULTS.Q1 SALES $27 MILLION VERSUS I/B/E/S VIEW $25 MILLION.PRELIMINARY PUMP SHIPMENTS INCREASED BY 56 PERCENT TO ABOUT 4,400 PUMPS IN Q1 OF 2018 FROM 2,816 PUMPS IN SAME PERIOD OF 2017.AS OF MARCH 31, 2018, CO HAD ABOUT $81.9 MLN IN CASH, CASH EQUIVALENTS, SHORT-TERM INVESTMENTS AND RESTRICTED CASH.  Full Article

Tandem Diabetes Care And Movi SpA Announce Agreement For Distribution Of Insulin Pump Products In Italy
Monday, 9 Apr 2018 09:00am EDT 

Tandem Diabetes Care Inc ::TANDEM DIABETES CARE AND MOVI SPA ANNOUNCE AGREEMENT FOR DISTRIBUTION OF INSULIN PUMP PRODUCTS IN ITALY.MOVI WILL PERFORM ALL SALES, MARKETING AND CUSTOMER TRAINING AND SUPPORT FOR TANDEM'S PRODUCTS.UNDER TERMS, MOVI WILL PERFORM ALL SALES, MARKETING AND CUSTOMER TRAINING AND SUPPORT FOR TANDEM'S PRODUCTS.TIMING FOR AVAILABILITY OF TANDEM PRODUCTS IN ITALY HAS NOT YET BEEN ANNOUNCED.ENTERED INTO A DISTRIBUTION AGREEMENT WITH MOVI SPA TO COMMERCIALIZE TANDEM'S T:SLIM X2 INSULIN PUMP IN ITALY.  Full Article

Tandem Diabetes Care Q4 Sales $40.3 Million
Thursday, 1 Mar 2018 04:00pm EST 

March 1 (Reuters) - Tandem Diabetes Care Inc ::TANDEM DIABETES CARE ANNOUNCES 2017 FINANCIAL RESULTS.Q4 SALES ROSE 39 PERCENT TO $40.3 MILLION.SEES FY 2018 SALES $132 MILLION TO $140 MILLION.QTRLY LOSS PER SHARE $1.23.‍SALES FOR Q1 OF 2018 ARE ESTIMATED TO BE 18 PERCENT - 19 PERCENT OF ANNUAL SALES​.Q4 EARNINGS PER SHARE VIEW $-1.30, REVENUE VIEW $36.7 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Tandem Diabetes Care Applies For Health Canada Medical Device License
Tuesday, 20 Feb 2018 04:30pm EST 

Feb 20 (Reuters) - Tandem Diabetes Care Inc ::TANDEM DIABETES CARE APPLIES FOR HEALTH CANADA MEDICAL DEVICE LICENSE.TANDEM DIABETES CARE INC - ‍PLANS TO LAUNCH PUMP IN CANADA IN SECOND HALF OF 2018.  Full Article

Tandem Diabetes Care Announces Pricing Of $60 Mln Underwritten Public Offering Of Common Stock
Friday, 9 Feb 2018 08:30am EST 

Feb 9 (Reuters) - Tandem Diabetes Care Inc ::TANDEM DIABETES CARE ANNOUNCES PRICING OF $60 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 30.0 MILLION COMMON SHARES PRICED AT $2.00PER SHARE.  Full Article

Tandem Diabetes Care Sees Q4 2017 GAAP Sales Of About $39 Mln to $40 Mln
Tuesday, 9 Jan 2018 04:15pm EST 

Jan 9 (Reuters) - Tandem Diabetes Care Inc ::TANDEM DIABETES CARE ANNOUNCES PRELIMINARY 2017 RESULTS AND PROVIDES 2018 GUIDANCE.SEES FY 2018 SALES $132 MILLION TO $140 MILLION.SEES FY 2018 SALES UP ABOUT 23 TO 32 PERCENT.- PRELIMINARY Q4 ‍GAAP SALES INCREASED TO APPROXIMATELY $39 MILLION TO $40 MILLION FROM $28.9 MILLION IN 2016​.TANDEM DIABETES CARE - EXPECT Q4 PUMP SHIPMENTS INCREASED TO ABOUT 7,000 PUMPS.- 2018 GAAP SALES ARE ESTIMATED TO BE IN RANGE OF $132 MILLION TO $140 MILLION.FY2018 REVENUE VIEW $133.6 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Tandem Diabetes Care Says May Offer Combination Of Stock Not Exceeding $10.7 Mln
Monday, 18 Dec 2017 05:33pm EST 

Dec 18 (Reuters) - Tandem Diabetes Care Inc ::TANDEM DIABETES CARE SAYS MAY OFFER COMBINATION OF STOCK, PREFERRED STOCK, WARRANTS OR UNITS HAVING INITIAL OFFERING PRICE NOT EXCEEDING $10.7 MILLION.  Full Article

Tandem Diabetes Care Announces Retirement Of CFO And Successor Appointment
Thursday, 7 Dec 2017 04:30pm EST 

Dec 7 (Reuters) - Tandem Diabetes Care Inc ::TANDEM DIABETES CARE ANNOUNCES RETIREMENT OF CFO AND SUCCESSOR APPOINTMENT.SAYS CFO JOHN CAJIGAS TO RETIRE, EFFECTIVE DECEMBER 31, 2017.TANDEM DIABETES CARE SAYS LEIGH VOSSELLER, WILL BE PROMOTED TO CFO, EFFECTIVE JANUARY 1, 2018.  Full Article

BRIEF-Tandem Diabetes Care Receives CE Mark for t:slim X2 Insulin Pump

* TANDEM DIABETES CARE-ANNOUNCED RECEIPT OF CE MARK APPROVAL FOR T:SLIM X2 INSULIN PUMP WITH DEXCOM G5® MOBILE CONTINUOUS GLUCOSE MONITORING INTEGRATION